Facet has always embraced novel scientific and regulatory approaches to products aimed at the treatment and prevention of disease. In the fight against cancer, we acknowledge the importance of early detection (see our expertise with diagnostic radiopharmaceuticals) and tools for patient management.
We also recognize that advances in the understanding of the molecular biology of cancer have led to significant innovations which have often triggered the need for novel regulatory approaches and interactive, collaborative discussions with FDA. Personalized/precision medicine has become a reality and one that Facet has embraced with our clients and with FDA.
Since our inception, Facet Life Sciences has partnered with small organizations to get their oncology products through regulated development for the prevention, detection, treatment, and management of cancer and related indications. We’ve helped our clients progress small molecules, targeted radiotherapeutics, antibody-based immunotherapies, and novel combination products, to name a few.
Contact us today to see how we might help you get your product to and through FDA!